Skip to Content

V 50 (Venclexta 50 mg)

Generic Name: venetoclax

Pill with imprint V 50 is Beige, Capsule-shape and has been identified as Venclexta 50 mg. It is supplied by AbbVie Inc..

Venclexta is used in the treatment of chronic lymphocytic leukemia and belongs to the drug class miscellaneous antineoplastics. Venclexta 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for V 50

Venclexta

Generic Name:
venetoclax
Imprint:
V 50
Strength:
50 mg
Color:
Beige
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antineoplastics
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AbbVie Inc.
National Drug Code (NDC):
00074-0566

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide